Eve Health Group Limited has released a press release.
Sales Results Exceed Expectations for Faulding GlucoControl
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Earlier from EVE Health
- $1.6m Placement for Omni Innovation Investment
- Notification of Rights Issue Shortfall
- Omni Innovation Market Update
- Omni Innovation secures UK Distribution Deal
- Placement to Chinese Pharmaceutical and Investment Group
Later from EVE Health
- Omni Innovation - US Patent Notice of Allowance Received
- Southern Cross University Collaboration with Medic Honey
- Accelerating Portfolio Progress
- Omni Innovation Enters Chinese Distribution Agreement
- Revised Medical Honey Investment Structure
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health